Related references
Note: Only part of the references are listed.Statins in Liver Transplant Recipients: Rates of Use, Mortality and Rejection
R. Selim et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Statin use is associated with a reduced risk of fibrosis progression in chronic hepatitis C
Tracey G. Simon et al.
JOURNAL OF HEPATOLOGY (2015)
Liver Fibrosis Progression in Hepatitis C Virus Infection After Seroconversion
Adeel A. Butt et al.
JAMA INTERNAL MEDICINE (2015)
Severe hepatic injury associated with different statins in patients with chronic liver disease: A nationwide population-based cohort study
Chia-Hsuin Chang et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2015)
Statins and Hepatitis C Virus Infection: An Old Therapy With New Scope
Fadi Rzouq et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2014)
Statin use and risk of hepatocellular carcinoma in a US population
Katherine A. McGlynn et al.
CANCER EPIDEMIOLOGY (2014)
Statin Use in Patients with Cirrhosis: A Retrospective Cohort Study
Sonal Kumar et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Impact of Added Fluvastatin to Standard-of-Care Treatment on Sustained Virological Response in Naive Chronic Hepatitis C Patients Infected with Genotypes 1 and 3
Tanja Selic Kurincic et al.
INTERVIROLOGY (2014)
Matrix Conditions and KLF2-Dependent Induction of Heme Oxygenase-1 Modulate Inhibition of HCV Replication by Fluvastatin
Andrea Wuestenberg et al.
PLOS ONE (2014)
Blood Tests to Diagnose Fibrosis or Cirrhosis in Patients With Chronic Hepatitis C Virus Infection A Systematic Review
Roger Chou et al.
ANNALS OF INTERNAL MEDICINE (2013)
Statin use and risk of hepatocellular carcinoma
Shih-Wei Lai et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2013)
Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
Siddharth Singh et al.
GASTROENTEROLOGY (2013)
Statins and the Risk of Hepatocellular Carcinoma in Patients With Hepatitis C Virus Infection
Yu-Tse Tsan et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial-stellate cell deactivation induced by statins
Giusi Marrone et al.
JOURNAL OF HEPATOLOGY (2013)
A randomized controlled trial adding fluvastatin to peginterferon and ribavirin for naive genotype 1 hepatitis C patients
T. Bader et al.
JOURNAL OF VIRAL HEPATITIS (2013)
Fluvastatin Interferes with Hepatitis C Virus Replication via Microtubule Bundling and a Doublecortin-like Kinase-Mediated Mechanism
Naushad Ali et al.
PLOS ONE (2013)
Validation of a coding algorithm to identify patients with hepatocellular carcinoma in an administrative database
David S. Goldberg et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2013)
Statins and Pulmonary Fibrosis The Potential Role of NLRP3 Inflammasome Activation
Jin-Fu Xu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Statins inhibit expression of Thioredoxin reductase 1 in rat and human liver and reduce tumour development
Cristine Skogastierna et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C
Laurent Castera
GASTROENTEROLOGY (2012)
Metformin for Liver Cancer Prevention in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis
Zhi-Jiang Zhang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
A Comparison of Treatment Eligibility for Hepatitis C Virus in HCV-Monoinfected Versus HCV/HIV-Coinfected Persons in Electronically Retrieved Cohort of HCV-Infected Veterans
Adeel A. Butt et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2011)
Protective effects of statin on cardiac fibrosis and apoptosis in adrenomedullin-knockout mice treated with angiotensin II and high salt loading
Chii Yamamoto et al.
HYPERTENSION RESEARCH (2011)
Simvastatin modulates the adhesion and growth of hepatocellular carcinoma cells via decrease of integrin expression and ROCK
Borna Relja et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
Open-label, ascending dose, prospective cohort study evaluating the antiviral efficacy of Rosuvastatin therapy in serum and lipid fractions in patients with chronic hepatitis C
K. Patel et al.
JOURNAL OF VIRAL HEPATITIS (2011)
Hepatotoxicity Fears Contribute to Underutilization of Statin Medications by Primary Care Physicians
Fadi S. Rzouq et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2010)
Association of Diabetes Duration and Diabetes Treatment With the Risk of Hepatocellular Carcinoma
Manal M. Hassan et al.
CANCER (2010)
Statin Therapy and Serum Transaminases Among a Cohort of HCV-Infected Veterans
Louise M. Henderson et al.
DIGESTIVE DISEASES AND SCIENCES (2010)
Simvastatin inhibits cell growth and induces apoptosis and G0/G1 cell cycle arrest in hepatic cancer cells
Borna Relja et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2010)
Statins in the Treatment of Dyslipidemia in the Presence of Elevated Liver Aminotransferase Levels: A Therapeutic Dilemma
Rossana M. Calderon et al.
MAYO CLINIC PROCEEDINGS (2010)
Statins Inhibit Angiotensin II/Smad Pathway and Related Vascular Fibrosis, by a TGF-β-Independent Process
Raul Rodrigues Diez et al.
PLOS ONE (2010)
Hepatitis C virus hijacks host lipid metabolism
Gulam H. Syed et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2010)
Antimicrobial and Immunomodulatory Attributes of Statins: Relevance in Solid-Organ Transplant Recipients
Hsin-Yun Sun et al.
CLINICAL INFECTIOUS DISEASES (2009)
Hepatitis C Virus Infection and the Risk of Coronary Disease
Adeel A. Butt et al.
CLINICAL INFECTIOUS DISEASES (2009)
Effect of Hepatitis C Virus and Its Treatment on Survival
Adeel A. Butt et al.
HEPATOLOGY (2009)
Rates of HCV Treatment Eligibility Among HCV-Monoinfected and HCV/HIV-Coinfected Patients in Tertiary Care Referral Centers
Adeel A. Butt et al.
HIV CLINICAL TRIALS (2009)
Do statins reduce hepatitis C RNA titers during routine clinical use?
Kimberly A. Forde et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Fluvastatin inhibits hepatitis C replication in humans
Ted Bader et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Chemoembolization Combined with Pravastatin Improves Survival in Patients with Hepatocellular Carcinoma
Hannah Graf et al.
DIGESTION (2008)
Dysmetabolic changes associated with HCV: a distinct syndrome?
Amedeo Lonardo et al.
INTERNAL AND EMERGENCY MEDICINE (2008)
Safety of statin therapy in patients with preexisting liver disease
Mihai Daniel Onofrei et al.
PHARMACOTHERAPY (2008)
Efficacy and safety of high-dose pravastatin in hypercholesterolemic patients with well-compensated chronic liver disease: Results of a prospective, randomized, double-blind, placebo-controlled, Multicenter trial
James H. Lewis et al.
HEPATOLOGY (2007)
FIB-4: an inexpensive and accurate marker of fibrosis in HCV infection. comparison with liver biopsy and FibroTest
Adays Vallet-Pichard et al.
HEPATOLOGY (2007)
Management and treatment of hepatitis C viral infection: Recommendations from the department of veterans affairs hepatitis C resource center program and the national hepatitis C program office
Helen S. Yee et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2006)
Different anti-HCV profiles of statins and their potential for combination therapy with interferon
Masanori Ikeda et al.
HEPATOLOGY (2006)
Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids
SB Kapadia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Simvastatin enhances hepatic nitric oxide production and decreases the hepatic vascular tone in patients with cirrhosis
C Zafra et al.
GASTROENTEROLOGY (2004)
Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantation
SA Haji et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2004)
Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis
HF Nadrous et al.
CHEST (2004)
Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial
S Kawata et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
